^
Association details:
Biomarker:No biomarker
Cancer:Hodgkin Lymphoma
Regimen:GDP (cisplatin + dexamethasone injection + gemcitabine)
Direction:Sensitive
Evidence:
Evidence Level:
Sensitive: A2 - Guideline
New
Source:
Excerpt:
Pediatric Hodgkin Lymphoma...Relapsed/Refractory Disease...Subsequent Therapy Options...GDP (gemcitabine, dexamethasone, cisplatin)